Document is current
Any future updates will be listed below
-
Authors
Lampl, Christian https://orcid.org/0000-0003-1756-1181
Kraus, Viktoria
Lehner, Katrina
Loop, Brett
Chehrenama, Mahan
Maczynska, Zofia
Ritter, Shannon
Klatt, Jan
Snellman, Josefin
-
Funding
Funding for this research was provided by:
Novartis Pharma AG, Basel, Switzerland (NA, NA, NA, NA, NA, NA)
- License Information
-
More Information
Article History
Received: 22 June 2022
Accepted: 23 July 2022
First Online: 18 August 2022
Declarations
:
: Approval for each study was provided by the Independent Ethics Committee or Institutional Review Board of the study sites. The list of the IEC or IRB for each study has been provided in the Additional file . The studies were conducted in accordance with Good Clinical Practice guidelines, the principles of the Declaration of Helsinki, and all applicable regulatory requirements. Participants provided written informed consent prior to initiation of any study procedures.
: Not applicable.
: Christian Lampl received honoraria from Novartis for given lectures and his participation in Advisory Board Meetings.Victoria Krauss declares that they have no competing interests.Katharina Lehner declares that they have no competing interests.Mahan Chehrenama is an employee of, and holds stock in Amgen Inc.Zofia Maczynska is a former employee of Novartis.Jan Klatt is a former employee of, and holds stock in Novartis.Brett Loop was an employee of Amgen Inc., US at the time of study conduct.Brett Loop, Shannon Ritter and Josefin Snellman are employees of, and hold stocks in Novartis.
